Hepatitis A Vaccine Market Revenue 2024 to 2034
Hepatitis A Vaccine Market Revenue 2024 to 2034
The hepatitis A vaccine market was estimated at US$ 742.31 million in 2023 and is projected to grow to US$ 948.16 million by 2034, rising at a compound annual growth rate (CAGR) of 2.25% from 2024 to 2034. The increasing outbreaks of hepatitis A, increasing awareness about immunization, and increase in travel and tourism.
Report ID: 10285
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 759.01 Bn
Forecast Year,
USD US$ 948.16 Mn
CAGR, 2025 -
2.25%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Hepatitis A Vaccine Market Size Analysis
Hepatitis A Vaccine Market Size By Type 2024 to 2034 (USD )
| Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactivated Vaccine | 531.31 | 541.71 | 552.31 | 563.11 | 574.13 | 585.35 | 596.78 | 608.44 | 620.31 | 632.41 | 644.75 |
| Live Attenuated Vaccine | 227.70 | 234.38 | 241.24 | 248.29 | 255.54 | 262.98 | 270.63 | 278.50 | 286.58 | 294.88 | 303.41 |
Hepatitis A Vaccine Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Government Institutions | 417.46 | 425.30 | 433.28 | 441.40 | 449.68 | 458.10 | 466.67 | 475.40 | 484.28 | 493.32 | 502.52 |
| Private Sectors | 265.65 | 273.18 | 280.92 | 288.86 | 297.02 | 305.40 | 314.00 | 322.84 | 331.92 | 341.24 | 350.82 |
| Others | 75.90 | 77.61 | 79.35 | 81.14 | 82.97 | 84.83 | 86.74 | 88.69 | 90.69 | 92.73 | 94.82 |
Hepatitis A Vaccine Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 227.70 | 231.27 | 234.89 | 238.55 | 242.26 | 246.02 | 249.82 | 253.66 | 257.56 | 261.50 | 265.48 |
| Asia Pacific | 227.70 | 235.15 | 242.83 | 250.72 | 258.85 | 267.22 | 275.84 | 284.71 | 293.83 | 303.23 | 312.89 |
| Europe | 151.80 | 155.99 | 160.30 | 164.72 | 169.25 | 173.91 | 178.69 | 183.60 | 188.63 | 193.80 | 199.11 |
| Latin America | 75.90 | 76.83 | 77.77 | 78.71 | 79.65 | 80.59 | 81.54 | 82.48 | 83.43 | 84.38 | 85.33 |
| Middle East and Africa | 75.90 | 76.83 | 77.77 | 78.71 | 79.65 | 80.59 | 81.54 | 82.48 | 83.43 | 84.38 | 85.33 |
Hepatitis A Vaccine Market Revenue 2024 to 2034
Hepatitis A Vaccine Market Revenue 2024 to 2034
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
